SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062822-21-000009
Filing Date
2021-03-10
Accepted
2021-03-10 16:12:22
Documents
15
Period of Report
2021-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20210310.htm   iXBRL 8-K 32688
2 EX-99.1 pressreleaseearnings03-10x.htm EX-99.1 94289
  Complete submission text file 0001062822-21-000009.txt   277124

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20210310.xsd EX-101.SCH 2426
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lxrx-20210310_cal.xml EX-101.CAL 712
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lxrx-20210310_def.xml EX-101.DEF 1645
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20210310_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20210310_pre.xml EX-101.PRE 12648
8 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20210310_htm.xml XML 10541
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 21729809
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences